In May 2026, Ken Paxton announced a settlement with Texas Children's Hospital in Houston after a three-year investigation into gender transition procedures and treatments for minors. The Justice Department worked with Paxton's office on the agreement.
Under the settlement, the hospital will pay $10 million, stop providing gender transition care for minors, fire and revoke the privileges of five doctors, and open what's believed to be the country's first "detransition clinic," with its services fully funded by the hospital for five years. The hospital did not admit wrongdoing. Paxton called it "a monumental day."
Children deserve to be protected, and Ken Paxton has never been afraid to take on the toughest fights to do it. Kids who want to detransition now have a place to turn for help. This is one of the most significant settlements of its kind in the country, and it happened in Texas because Ken Paxton didn't back down. 🇺🇸
#Houston
Republican for Trump
TX Hospitals & Health Systems
🏥🌎 One Houston neighborhood holds more medical institutions than most countries' entire healthcare systems... and it never sleeps! 🤯
The Texas Medical Center in Houston, Texas is widely recognized as the largest medical complex in the world, with more than 60 member institutions packed into one district, including world-famous names like MD Anderson Cancer Center, Texas Children's Hospital, Houston Methodist, and Baylor College of Medicine. It covers over 1,000 acres and handles more than 10 million patient encounters every year, with well over 100,000 people working there every day, which makes it feel more like a small city than a neighborhood. Its roots go back to 1945, and since then it has been home to major medical milestones, including Dr. Denton Cooley's first total artificial heart implant in a human in 1969 at the Texas Heart Institute. Today it brings together hospitals, research labs, medical schools, nursing programs, and biotech companies, all within walking distance of each other. Did you know a place like this existed in the US, and would you ever guess it's in Houston? 👇
#TexasMedicalCenter #houston #texasliving #HealthCare #DidYouKnow
Houston, Texas Medical Center, Largest Medical Center in the World, Healthcare, Medical Innovation, Geography Facts, Map Facts
#Houston#Houston#Houston
America Mapped
TX Hospitals & Health Systems
New ABC13 Houston Upload: Texas Children's Hospital staff and former patients ring bell to honor their journey
#Houston
yt-app
TX Hospitals & Health Systems
I looked at ~226,000 public job postings across 8 big US metros. 6 things that should change how you job hunt.
I looked at the data from public job postings on employers' own career sites (their jobs pages, not the reposts on Indeed or LinkedIn) in 8 metro areas: New York, LA, Chicago, Dallas-Fort Worth, Houston, Atlanta, Boston and the SF Bay Area. About 226,000 open postings in total. A few patterns showed up in every city, and a couple of them go against what people usually assume.
|Metro|Open postings|Fully remote|Biggest single employer|What dominates|
|:-|:-|:-|:-|:-|
|SF Bay Area|53,000|3.3%|Apple|Tech (41% of postings)|
|New York|46,000|4.0%|City of New York|Retail/hospitality, then a wide mix|
|Los Angeles|30,000|3.4%|Anduril|Aerospace/defense and industrial (26%)|
|Dallas-Fort Worth|27,000|3.8%|Methodist Health System|Retail/consumer (26%)|
|Chicago|19,500|4.2%|Northwestern Medicine|Healthcare (26%)|
|Houston|18,300|3.9%|Texas Children's Hospital|Industrial (28%) and energy (9%)|
|Boston|16,900|4.3%|Boston Medical Center|Healthcare (32%)|
|Atlanta|15,600|4.8%|Technical College System of Georgia|Retail/consumer and industrial|
**1. Remote is rare everywhere, including the Bay Area.**
Fully remote postings were between 3% and 5% in every single metro. The Bay Area was actually the lowest at 3.3%. If you're searching remote-only, you're looking at roughly 1 in 25 jobs. Widening to hybrid or local roles is the biggest single change most people can make to how many jobs they can apply to.
**2. In 6 of 8 cities, the biggest employer is a hospital system or a public institution.**
City of New York, Northwestern Medicine, Methodist Health, Texas Children's, the Technical College System of Georgia and Boston Medical Center were each the largest single poster in their metro. Big hospital systems and public bodies also hire for IT, finance, HR, facilities, admin and project management, so they're worth a look even if you don't see yourself as a "hospital person" or a "government person".
**3. Outside the Bay Area, tech companies are a small slice.**
Tech companies were 41% of postings in the Bay Area, but only 3% to 13% everywhere else. In Boston, New York and LA they were around 11 to 13%, in Chicago, Dallas and Atlanta about 7 to 8%, and in Houston 3%. Software developer is still one of the most common roles in most of these cities, even though tech companies make up a small share of all postings. If you're a developer or analyst only applying to "tech companies", you're likely skipping a lot of the openings in your own city.
**4. Most jobs aren't in the city everyone searches.**
In the Bay Area, about two thirds of postings are outside San Francisco itself (Santa Clara, San Jose, Sunnyvale, Palo Alto, Mountain View). In LA it's about 60% outside the city of Los Angeles (Irvine, El Segundo, Costa Mesa, Long Beach, Torrance). In Dallas-Fort Worth over half are outside Dallas (Fort Worth, Plano, Irving, Arlington, Frisco). Boston has almost 40% outside the city (Cambridge, Waltham, Quincy). If your job alerts are set to the main city name only, you're missing a big part of your own market.
**5. Every city has its own hiring engine, so tailor your targets.**
* LA: aerospace and defense (Anduril, SpaceX, Aerospace Corp, Relativity Space, Rocket Lab), plus USC and UCLA Health
* Boston: hospitals, universities and biotech (Boston Medical Center, Harvard, Mass General Brigham, Dana-Farber, Vertex)
* Chicago: hospital systems (Northwestern, Endeavor, Advocate, Lurie Children's) plus finance (Northern Trust)
* Houston: hospitals (Texas Children's, Houston Methodist, Harris Health) and energy
* New York: city government, hospitals, ad agencies and media (Interpublic, NBCUniversal), banks
* Bay Area: chips and AI (Apple, NVIDIA, Applied Materials, OpenAI, Google)
If your background fits one of these, it's worth going straight to those employers' career pages rather than waiting for them to show up in a job board search.
**6. Almost everything is full-time.**
Between 88% and 93% of postings were full-time in every metro. Part-time was 6% to 11%, and contract work barely shows up on employer career sites at all (under 1% in every metro). If you're specifically after contract work, employer career sites don't seem to be where most of it gets advertised.
**How much to trust this**
Treat the counts as a map of where employers are advertising, not a count of people being hired. Some companies leave the same opening up for months or post one role hundreds of times, so the rankings favor big, always-recruiting employers. The data also leans toward organizations big enough to run their own careers page, which means small shops that only use Indeed or Craigslist are underrepresented. Pulling this together from thousands of different career sites isn't easy, so think of it as a best-effort snapshot rather than an official count. I also kept salary out entirely because the figures weren't reliable enough to quote.
If you only change three things after reading this: apply on the employer's own site, set your alerts to the whole metro instead of the city name, and drop the remote-only and tech-only filters unless you genuinely need them.
#Houston#Houston#Houston#DFW
WorkhuntersOfficial
TX Hospitals & Health Systems
A 3-year-old boy's chemotherapy-resistant liver cancer disappeared after two doses of a novel immunotherapy. The treatment was made from his own cells and administered entirely in the outpatient setting. One year later, he remains cancer-free.
This is a case report published in the New England Journal of Medicine by researchers at Baylor College of Medicine, Texas Children's Hospital, and Seattle Children's.
The patient was a 3-year-old boy who presented with a large primary liver tumor — 11.2 cm by 9.6 cm by 7.1 cm — and metastases in his lungs. The cancer had also shown signs of spreading to his bones. He underwent three lines of chemotherapy and complete surgical resection of the primary liver tumor and two lung metastases. His cancer stopped responding to chemo. Then a new lung metastasis appeared after surgery.
He was enrolled in the CARE study (NCT04715191), a first-in-human Phase 1 trial evaluating glypican-3-specific chimeric antigen receptor (GPC3-CAR) T cells armed with interleukin-15 and -21.
GPC3 is a protein highly expressed in liver cancers. The researchers took the boy's own T cells and engineered them to recognize GPC3, then added genes for IL-15 and IL-21 to boost the CAR T cells' longevity and tumor-killing ability. They also included an inducible caspase 9 safety switch, which researchers had previously shown could control CAR T expansion if needed.
The treatment was manufactured at the Center for Cell and Gene Therapy at Baylor. Two infusions were administered eight weeks apart — entirely in the outpatient setting. After the first infusion, the patient showed a partial response. After the second infusion, imaging showed complete resolution of the metastatic disease. No dose-limiting toxicities or cytokine release syndrome occurred.
Complete regression continues one year after treatment.
"This case demonstrates that a durable complete response in a chemotherapy-resistant solid tumor can be achieved entirely in the outpatient setting without systemic toxicity," said first author Dr. David Steffin, associate chief of cellular therapy at Texas Children's.
"This study provides evidence that these novel CAR T cells may be a safe and effective modality for hepatoblastoma and highlights the need for further assessment in patients with GPC3+ solid tumors," said corresponding author Dr. Andras Heczey.
CAR T cell therapy has mostly been limited to blood cancers, not solid tumors. This case suggests that boundary might be moving.
#Houston
Electronic-Bus-3494
TX Hospitals & Health Systems
Severe Pulmonary Hypertension of the Newborn (PPHN) – Our 54-Day Journey, ECMO, and What I Wish I Knew
Our daughter Adeline was born July 29, 2026, and passed away September 21, after 54 days battling severe persistent pulmonary hypertension of the newborn (PPHN).
I'm sharing our experience because I spent countless nights searching Reddit for stories similar to ours and couldn't find many that covered the entire journey.
Before anything else, here's what I want every NICU parent to know:
\- You are your child's advocate. You know their patterns, triggers, and what works. Speak up, even when you're surrounded by specialists.
\- Slow down. With severe PPHN, I believe patience is incredibly important. Everyone wants their baby home, but trying to accomplish too much too quickly can lead to devastating setbacks.
\- Don't be afraid to say, "She's been through enough today." We had to tell staff this repeatedly. Sometimes the best thing for our daughter was to leave her alone and let her recover.
\- Be present for rounds. Ask about every medication, procedure, ventilator adjustment, and treatment plan.
\- Request family conferences. Get the attending physicians, specialists, nurses, and other relevant teams together so everyone understands the plan and your concerns.
\- Document everything. I used ChatGPT throughout our journey to help understand blood gases, echocardiograms, medications, and treatment options. I kept a timeline of her progress and setbacks. It helped me ask better questions and recognize patterns.
\- Dont be to proud to ask for prayers. Putting our story on social media brought so many people closer to God that in the end that also gave us a feeling of comfort.
Days 1–5: Diagnosis
Adeline was born seemingly healthy. Approximately 48 hours later, her oxygen saturation dropped into the 60s.
She was intubated and diagnosed with severe PPHN, pneumonia, and suspected meconium aspiration syndrome.
We spent 4 days at our delivery hospital and Adeline made great progress at weaning her suppprt but when we got to 40% FIO Support and 3% Nitric support we had our first big set back.
She was receiving antibiotics, inhaled nitric oxide, and mechanical ventilation. Eventually, her condition required transfer to an ECMO center.
One thing nobody prepares you for is the NICU environment. Some rooms are incredibly small pods with barely enough room for a chair. You spend days and nights sitting beside your child, trying to understand medical terminology while running on almost no sleep.
My advice: document everything from day one. Ask for copies of results and write down questions before rounds. ChatGPT became a valuable tool for translating medical information into language I could understand, although I always brought my questions back to her medical team.
Days 6–21: VA ECMO
On August 6, Adeline was placed on VA ECMO to support her heart and lungs.
Her pulmonary pressures remained extremely high despite medications including nitric oxide, milrinone, sildenafil, treprostinil, bosentan, and others.
Her CT showed diffuse lung disease, and genetic testing was pursued. Doctors even discussed rare developmental lung conditions. We did genetic test which took weeks, results were negative but didn't mean there still wasnt underlying developmental problems with her lungs.
Her first ECMO clamp trial failed when her oxygen saturation dropped into the 40s.
On August 18, she successfully came off VA ECMO.
My advice during this stage: Attend rounds every morning. Don't just listen; participate. Ask what the plan is, why medications are changing, and what happens if the current approach fails.
If different specialists are giving different answers, request a family conference. You deserve to understand the entire picture.
Days 22–37: VV ECMO
Shortly after coming off VA ECMO, Adeline experienced another severe respiratory event involving mucus obstruction.
On August 20, she was placed on VV ECMO to support her lungs.
Over the next two weeks, her oxygen requirements improved, her ventilator settings decreased, and she began tolerating less support.
On September 3, she successfully came off ECMO again.
Looking back, part of me wishes we could have stayed on VV ECMO longer to give her lungs more time to heal. I understand ECMO carries serious risks, including bleeding, infection, and complications from prolonged support. I don't know whether staying on longer would have changed anything.
But I wish we had discussed the balance between those risks and the possibility that her lungs simply needed more time.
Days 38–52: The Setbacks
This was probably the most frustrating stage.
Adeline was improving. Her oxygen requirements decreased, and we started working toward extubation.
But she was still EXTREMELY sensitive to stimulation.
Repositioning, suctioning, waking up, or changing ventilator settings could trigger pulmonary hypertensive crises. Her blood pressure and heart rate would spike, and sometimes her oxygen saturation would drop into the 40s or 50s.
We learned what worked for her. Sometimes she needed suctioning. Other times she needed a quiet room, minimal handling, and time to settle.
There were days when doctors wanted to accomplish several things: reposition her breathing tube, obtain X-rays, change medications, adjust ventilator settings, and reduce sedation.
We started telling staff, "No. She's been through enough today."
Looking back, I wish we had said it sooner and more often.
Many of her nurses understood this. Some believed the best thing for her was simply more time to recover.
I know medical teams have goals and milestones, but I wish we had pushed harder to make sure those goals were approached at HER pace.
Days 53–54: Transfer to Texas Children's Hospital
We transferred Adeline to Texas Children's Hospital in Houston on September 20 because we wanted additional pulmonary hypertension expertise.
Looking back, I wish we had transferred on a weekday rather than a weekend. At major hospitals, emergency specialists are available around the clock, but the full multidisciplinary team and program leadership may not be present in the same way on weekends.
I wish we had arrived on a Tuesday, when more of the team could have evaluated her together and developed a plan before making significant changes.
The new team adjusted her ventilator settings, medications, and introduced inhaled epoprostenol.
Our concern was that they were trying to optimize too many things too quickly.
We explained how sensitive she was. We explained her history with repositioning, suctioning, stimulation, and how we had learned to manage these things at the previous hospital.
But we felt that because we were new patients, the team needed to see her responses for themselves rather than fully relying on what we had already learned.
I wish they had listened more closely.
I wish we had insisted on maintaining the suctioning and repositioning approaches that had worked for her until the new team had time to understand her.
I wish we had pushed harder for fewer changes and more time between interventions.
On September 21, our daughter passed away.
I cannot say whether a slower approach would have changed her ultimate outcome. Her pulmonary hypertension was incredibly severe, and we knew she was critically ill.
But I will always wonder whether we could have given her more time.
My Final Advice to Parents
I know how badly you want this nightmare to end. You want your baby off ECMO, off the ventilator, out of the NICU, and finally home.
We wanted that more than anything.
But don't let the desire to reach the next milestone overshadow what your child can tolerate today.
Ask whether a procedure is necessary right now. Ask whether multiple changes can be separated. Ask whether your child needs another day to recover before attempting the next step.
Understand that sometimes urgent interventions cannot wait, but make sure your child's individual response is part of every decision.
If you're transferring hospitals, ask for a detailed handoff that includes not only medications and test results but also your child's triggers, handling preferences, suctioning approach, and what has previously caused crises.
And please, don't underestimate the nurses who have spent weeks at your baby's bedside. Their observations matter. These relationships are probably the most important to establish while going through this and in someways they become secondary family to you and your baby. They can also help with questions you might want to ask the dr.
Our daughter fought through two ECMO runs, countless procedures, and 54 days of severe pulmonary hypertension.
I wish I were writing this from home with her in my arms.
Instead, I'm writing it hoping another parent finds the information I was desperately searching for.
Her name was Adeline Jimenez. We called her Ade.
She was here for 54 days, and she changed our lives forever.
Feel free to DM me with any questions we are happy to help and share our experience.
#Houston
Gabrieljim3630
TX Hospitals & Health Systems
